| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |